• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性体内的睾酮与心血管风险

Testosterone and cardiovascular risk in men.

作者信息

Kelly Daniel M, Jones T Hugh

机构信息

Department of Human Metabolism, Medical School, The University of Sheffield, Sheffield, UK.

出版信息

Front Horm Res. 2014;43:1-20. doi: 10.1159/000360553. Epub 2014 Jun 10.

DOI:10.1159/000360553
PMID:24943294
Abstract

Testosterone deficiency is highly prevalent in men with cardiovascular disease (CVD) and is associated with an increased mortality. Low testosterone also has an adverse effect on several cardiovascular risk factors, which include insulin resistance, diabetes, dyslipidaemia, central adiposity and endothelial dysfunction. Male gender is a well-recognised risk factor for premature CVD and mortality. The question of whether or not testosterone deficiency is a contributory factor to atherogenesis or merely a biomarker of ill health arises. Animal studies and experiments on isolated cells indicate that many of the mechanisms intimate to the atherosclerotic process are beneficially modulated by testosterone. Epidemiological studies have shown that men with endogenous testosterone levels in the mid-upper normal range have reduced cardiovascular events and mortality compared to those with low or lower range, and with high range testosterone. Testosterone replacement in men diagnosed with hypogonadism where mid-normal range levels are achieved have shown a beneficial effect on several cardiovascular risk factors, cardiac ischaemia, functional exercise capacity and improved mortality. Yet studies where patients were either undertreated or given high-dose testosterone have been associated with an increased risk of cardiovascular-related events. Clinical monitoring and titration of testosterone dose is therefore of paramount importance.

摘要

睾酮缺乏在心血管疾病(CVD)男性患者中极为普遍,且与死亡率增加相关。低睾酮水平还对多种心血管危险因素产生不利影响,这些因素包括胰岛素抵抗、糖尿病、血脂异常、中心性肥胖和内皮功能障碍。男性性别是公认的早发性CVD和死亡的危险因素。于是出现了一个问题,即睾酮缺乏究竟是动脉粥样硬化发生的一个促成因素,还是仅仅是健康状况不佳的一个生物标志物。动物研究和对分离细胞的实验表明,许多与动脉粥样硬化过程密切相关的机制都受到睾酮的有益调节。流行病学研究表明,与睾酮水平处于低范围或高范围的男性相比,内源性睾酮水平处于中高正常范围的男性心血管事件和死亡率更低。对被诊断为性腺功能减退的男性进行睾酮替代治疗,使睾酮水平达到正常范围时,已显示出对多种心血管危险因素、心肌缺血、功能运动能力及死亡率改善都有有益影响。然而,那些患者治疗不足或给予高剂量睾酮的研究与心血管相关事件风险增加有关。因此,睾酮剂量的临床监测和滴定至关重要。

相似文献

1
Testosterone and cardiovascular risk in men.男性体内的睾酮与心血管风险
Front Horm Res. 2014;43:1-20. doi: 10.1159/000360553. Epub 2014 Jun 10.
2
The dark side of testosterone deficiency: III. Cardiovascular disease.睾酮缺乏的负面影响:III. 心血管疾病
J Androl. 2009 Sep-Oct;30(5):477-94. doi: 10.2164/jandrol.108.007245. Epub 2009 Apr 2.
3
Testosterone and mortality.睾酮与死亡率
Clin Endocrinol (Oxf). 2014 Oct;81(4):477-87. doi: 10.1111/cen.12503. Epub 2014 Jul 7.
4
Testosterone, cardiovascular disease and the metabolic syndrome.睾酮、心血管疾病和代谢综合征。
Best Pract Res Clin Endocrinol Metab. 2011 Apr;25(2):337-53. doi: 10.1016/j.beem.2010.07.002.
5
Testosterone deficiency: a risk factor for cardiovascular disease?睾酮缺乏:心血管疾病的危险因素?
Trends Endocrinol Metab. 2010 Aug;21(8):496-503. doi: 10.1016/j.tem.2010.03.002. Epub 2010 Apr 8.
6
Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?男性睾酮缺乏症的雄激素治疗:睾酮能否降低心血管疾病风险?
Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:52-9. doi: 10.1002/dmrr.2354.
7
Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.随机对照试验——睾酮与心血管系统的机制研究
Asian J Androl. 2018 Mar-Apr;20(2):120-130. doi: 10.4103/aja.aja_6_18.
8
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.睾酮缺乏与死亡率增加有关,而睾酮替代治疗可改善 2 型糖尿病男性的生存。
Eur J Endocrinol. 2013 Oct 21;169(6):725-33. doi: 10.1530/EJE-13-0321. Print 2013 Dec.
9
Testosterone: a vascular hormone in health and disease.睾酮:一种在健康和疾病中的血管激素。
J Endocrinol. 2013 May 7;217(3):R47-71. doi: 10.1530/JOE-12-0582. Print 2013 Jun.
10
[Male hypogonadism and civilization diseases].[男性性腺功能减退与文明病]
Cas Lek Cesk. 2012;151(2):69-72.

引用本文的文献

1
Associations between endogenous sex hormone levels and adipokine levels in the Multi-Ethnic Study of Atherosclerosis.动脉粥样硬化多民族研究中内源性性激素水平与脂肪因子水平之间的关联。
Front Cardiovasc Med. 2023 Jan 13;9:1062460. doi: 10.3389/fcvm.2022.1062460. eCollection 2022.
2
Sex-specific differences in atherosclerosis, thrombospondin-1, and smooth muscle cell differentiation in metabolic syndrome versus non-metabolic syndrome mice.代谢综合征与非代谢综合征小鼠在动脉粥样硬化、血小板反应蛋白-1及平滑肌细胞分化方面的性别差异。
Front Cardiovasc Med. 2022 Nov 23;9:1020006. doi: 10.3389/fcvm.2022.1020006. eCollection 2022.
3
Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin.
二甲双胍对胰岛素治疗的 2 型糖尿病男性患者睾酮水平的影响。
Front Endocrinol (Lausanne). 2021 Dec 24;12:813067. doi: 10.3389/fendo.2021.813067. eCollection 2021.
4
The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts.雄激素对心脏代谢综合征的影响:当前的治疗理念
Sex Med. 2020 Jun;8(2):132-155. doi: 10.1016/j.esxm.2020.02.006. Epub 2020 Mar 20.
5
Testosterone, myocardial function, and mortality.睾酮、心肌功能与死亡率。
Heart Fail Rev. 2018 Sep;23(5):773-788. doi: 10.1007/s10741-018-9721-0.
6
Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups.长期睾酮治疗可改善性腺功能减退男性的心脏代谢功能并降低心血管疾病风险:一项比较治疗组和未治疗(对照)组的真实世界观察性登记研究
J Cardiovasc Pharmacol Ther. 2017 Sep;22(5):414-433. doi: 10.1177/1074248417691136. Epub 2017 Feb 9.
7
Will testosterone replacement therapy become a new treatment of chronic heart failure? A review based on 8 clinical trials.睾酮替代疗法会成为慢性心力衰竭的一种新疗法吗?一项基于8项临床试验的综述。
J Thorac Dis. 2016 May;8(5):E269-77. doi: 10.21037/jtd.2016.03.39.
8
Serum sex hormone and growth arrest-specific protein 6 levels in male patients with coronary heart disease.男性冠心病患者血清性激素和生长停滞特异性蛋白6水平
Asian J Androl. 2016 Jul-Aug;18(4):644-9. doi: 10.4103/1008-682X.172825.
9
Effects of bariatric surgery on markers of subclinical atherosclerosis and endothelial function: a meta-analysis of literature studies.减肥手术对亚临床动脉粥样硬化标志物和内皮功能的影响:文献研究的荟萃分析
Int J Obes (Lond). 2016 Mar;40(3):395-402. doi: 10.1038/ijo.2015.187. Epub 2015 Sep 21.
10
Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone.接受注射用睾酮治疗的年轻健康男性的心肌梗死和中风风险
Int J Endocrinol. 2015;2015:970750. doi: 10.1155/2015/970750. Epub 2015 Jun 1.